Medicine & Life Sciences
Urinary Bladder Neoplasms
100%
Prostatic Neoplasms
44%
Survival
18%
Radiotherapy
18%
Biomarkers
15%
Neoplasms
15%
Iron
15%
Nitroreductases
13%
Therapeutics
12%
Renal Cell Carcinoma
12%
Muscles
12%
Transferrin
12%
ZD4054
11%
Randomized Controlled Trials
11%
Docetaxel
11%
Zoledronic Acid
11%
Strontium-89
11%
Castration
11%
Fluorescence
10%
Hormones
9%
Drug Therapy
9%
Prodrugs
9%
Urinary Bladder
9%
N-terminal monoferrictransferrin
9%
Recurrence
8%
Neoplasm Metastasis
8%
tretazicar
8%
Epithelial Cell Adhesion Molecule
8%
Transitional Cell Carcinoma
8%
Prostate-Specific Antigen
7%
Chemoradiotherapy
7%
Genes
7%
Placebos
7%
Tryptophan
7%
Bone and Bones
6%
Cystectomy
6%
Indoleacetic Acids
6%
Adenoviridae
6%
Clinical Trials
6%
abiraterone
6%
Endothelin A Receptor Antagonists
6%
Protein-Tyrosine Kinases
6%
Carbonic Anhydrase IX
6%
Cohort Studies
5%
High-Throughput Nucleotide Sequencing
5%
Granulocyte-Macrophage Colony-Stimulating Factor
5%
Carbonic Anhydrase Inhibitors
5%
Enzyme Therapy
5%
Proteins
5%
Platinum
5%